Breaking News Instant updates and real-time market news.

LCI

Lannett

$5.29

0.03 (0.57%)

06:57
06/18/19
06/18
06:57
06/18/19
06:57

Lannett commences marketing for Aspirin, Dipyridamole Capsules

Lannett announced that it has commenced marketing Aspirin and extended-release Dipyridamole Capsules, the therapeutic equivalent to the reference listed drug, Aggrenox of Boehringer Ingelheim Pharmaceuticals. Total U.S. sales of Aspirin and extended-release Dipyridamole Capsules was approximately $158M for the 12 months ended April, according to IQVIA, although actual generic market values are expected to be lower.

LCI Lannett
$5.29

0.03 (0.57%)

05/13/19
WELS
05/13/19
NO CHANGE
WELS
Lawsuit against Teva, others to hit generic drug stocks, says Wells Fargo
Wells Fargo analyst David Maris believes the lawsuit by 44 states against 20 generic drugmakers will weigh on generic drug stocks this week and remain an "overhang issue for some time." Actual penalties and damages are impossible to calculate, but could be material, Maris tells investors in a research note. The analyst spoke to the Connecticut attorney general's office this morning and learned they are preparing for trial in these cases. Language the attorney general has used, such as "unprecedented" and his desire to clawback all gains from collusion, should be indicative of the states' intent, Maris writes. He believes that for a sector that is generally highly levered, and with some companies named already facing an overhang from opioid litigation like Teva (TEVA), this is "especially unwelcome news."
03/19/19
RHCO
03/19/19
INITIATION
Target $9
RHCO
Hold
Lannett initiated with a Hold at SunTrust
SunTrust analyst Gregg Gilbert started Lannett with a Hold rating and $9 price target. The analyst says that while the stock's most important overhang has been removed with the loss of levothyroxine, he sees the risk/reward as relatively balanced at current share levels.
08/20/18
BMOC
08/20/18
NO CHANGE
BMOC
Market Perform
Lannett price target lowered to $8 from $19 at BMO Capital
BMO Capital analyst Gary Nachman said JSP's decision to not renew its agreement with Lannett (LCI) and go with Amneal Pharmaceuticals (AMRX) is an "unfortunate development" that impacts three products, including Levothyroxine, which accounts for about 35-40% of Lannett revenue and is "very profitable." He lowered his estimates "significantly" due to this "major setback" and cut his price target on Lannett shares to $8 from $19 while maintaining a Market Perform rating on the shares.
08/20/18
08/20/18
DOWNGRADE

Market Perform
Lannett downgraded to Market Perform as JSP walks away from renewal at Raymond James
As previously reported, Raymond James analyst Elliot Wilbur downgraded Lannett to Market Perform from Outperform after Jerome Stevens terminated its strategic distribution agreement with the company, a deal that provided Lannett with several key products but mainly levothyroxine, which is expected to account for 35% of FY18 sales and 44% of gross profit. From a monetary perspective, the analyst believes it makes "zero sense" why JSP would walk away from the deal, inflicting significant damage on its own holdings of Lannett shares. This suggests either JSP has no confidence in the recovery value of its holdings from current levels or has sold down or hedged a substantial portion of its holdings despite prior representations from Lannett management to the contrary, Wilbur contends.

TODAY'S FREE FLY STORIES

CLH

Clean Harbors

$75.14

-0.25 (-0.33%)

06:53
08/23/19
08/23
06:53
08/23/19
06:53
Initiation
Clean Harbors initiated  »

Clean Harbors resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROST

Ross Stores

$107.31

1.63 (1.54%)

06:53
08/23/19
08/23
06:53
08/23/19
06:53
Recommendations
Ross Stores analyst commentary  »

Ross Stores price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEB

Hemispherx

$1.89

-0.02 (-1.05%)

06:52
08/23/19
08/23
06:52
08/23/19
06:52
Hot Stocks
Hemispherx changes name to AIM ImmunoTech, effective September 3 »

Hemispherx Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BKE

The Buckle

$18.61

0.695 (3.88%)

06:50
08/23/19
08/23
06:50
08/23/19
06:50
Earnings
The Buckle reports Q2 EPS 34c, consensus 30c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

GPS

Gap

$17.75

0.79 (4.66%)

06:50
08/23/19
08/23
06:50
08/23/19
06:50
Recommendations
Gap analyst commentary  »

Gap price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

LNDC

Landec

$10.99

-0.07 (-0.63%)

06:50
08/23/19
08/23
06:50
08/23/19
06:50
Initiation
Landec initiated  »

Landec initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TELL

Tellurian

$9.19

0.9 (10.86%)

06:49
08/23/19
08/23
06:49
08/23/19
06:49
Downgrade
Tellurian rating change  »

Tellurian downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$203.43

-0.41 (-0.20%)

, ALXN

Alexion

$123.51

8.64 (7.52%)

06:48
08/23/19
08/23
06:48
08/23/19
06:48
Recommendations
Amgen, Alexion analyst commentary  »

Amgen deal for Alexion…

AMGN

Amgen

$203.43

-0.41 (-0.20%)

ALXN

Alexion

$123.51

8.64 (7.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 16

    Sep

  • 19

    Sep

  • 02

    Oct

  • 19

    Oct

FL

Foot Locker

$42.00

2.24 (5.63%)

06:47
08/23/19
08/23
06:47
08/23/19
06:47
Earnings
Foot Locker reports Q2 EPS ex-items 66c, consensus 67c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 19

    Sep

  • 25

    Sep

VWAGY

Volkswagen

$0.00

(0.00%)

06:47
08/23/19
08/23
06:47
08/23/19
06:47
Periodicals
Volkswagen looks for investment in China auto suppliers, Bloomberg says »

Volkswagen is considering…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPQ

HP Inc.

$18.91

-0.04 (-0.21%)

06:46
08/23/19
08/23
06:46
08/23/19
06:46
Recommendations
HP Inc. analyst commentary  »

HP Inc. price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

VMW

VMware

$148.15

0.11 (0.07%)

, PVTL

Pivotal Software

$13.69

0.01 (0.07%)

06:45
08/23/19
08/23
06:45
08/23/19
06:45
Recommendations
VMware, Pivotal Software, Carbon Black analyst commentary  »

VMware price target…

VMW

VMware

$148.15

0.11 (0.07%)

PVTL

Pivotal Software

$13.69

0.01 (0.07%)

CBLK

Carbon Black

$24.52

1.77 (7.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 10

    Sep

  • 10

    Oct

CEQP

Crestwood Equity

$35.83

-0.21 (-0.58%)

06:43
08/23/19
08/23
06:43
08/23/19
06:43
Upgrade
Crestwood Equity rating change  »

Crestwood Equity upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRM

Salesforce

$148.26

0.86 (0.58%)

06:39
08/23/19
08/23
06:39
08/23/19
06:39
Recommendations
Salesforce analyst commentary  »

Salesforce price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 28

    Aug

  • 12

    Dec

  • 16

    Dec

EFOI

Energy Focus

$0.47

-0.0022 (-0.47%)

06:39
08/23/19
08/23
06:39
08/23/19
06:39
Hot Stocks
Energy Focus receives Nasdaq notice of noncompliance »

Energy Focus announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHI

D.R. Horton

$50.34

0.89 (1.80%)

06:37
08/23/19
08/23
06:37
08/23/19
06:37
Initiation
D.R. Horton initiated  »

D.R. Horton initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

HIBB

Hibbett Sports

$17.01

0.845 (5.23%)

06:36
08/23/19
08/23
06:36
08/23/19
06:36
Hot Stocks
Hibbett Sports reports Q2 gross margin 30.3% »

Gross margin was 30.3% of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

HIBB

Hibbett Sports

$17.01

0.845 (5.23%)

06:35
08/23/19
08/23
06:35
08/23/19
06:35
Hot Stocks
Hibbett Sports CEO says 'pleased with the second quarter results' »

Jeff Rosenthal, President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

HIBB

Hibbett Sports

$17.01

0.845 (5.23%)

06:35
08/23/19
08/23
06:35
08/23/19
06:35
Hot Stocks
Hibbett Sports narrows FY20 CapEx view to $18M-$20M from $18M-$22M »

Raises FY20 share…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

PHM

PulteGroup

$33.16

0.27 (0.82%)

06:34
08/23/19
08/23
06:34
08/23/19
06:34
Initiation
PulteGroup initiated  »

PulteGroup initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

$46.76

-0.39 (-0.83%)

06:34
08/23/19
08/23
06:34
08/23/19
06:34
Periodicals
Intel introduces new-generation 14nm mobile chips, DigiTimes says »

Monica Chen and Joseph…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 24

    Oct

HPQ

HP Inc.

$18.91

-0.04 (-0.21%)

06:33
08/23/19
08/23
06:33
08/23/19
06:33
Recommendations
HP Inc. analyst commentary  »

HP Inc.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

HIBB

Hibbett Sports

$17.01

0.845 (5.23%)

06:33
08/23/19
08/23
06:33
08/23/19
06:33
Earnings
Hibbett Sports raises FY20 adj. EPS view to $2.15-$2.25 from $2.00-$2.15 »

FY20 consensus $2.10.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

KBH

KB Home

$28.48

0.31 (1.10%)

06:32
08/23/19
08/23
06:32
08/23/19
06:32
Initiation
KB Home initiated  »

KB Home initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTU

Intuit

$276.05

-0.29 (-0.10%)

06:32
08/23/19
08/23
06:32
08/23/19
06:32
Recommendations
Intuit analyst commentary  »

Intuit price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.